Dr. Ashwin Balagopal

Slingshot Insights recently conducted an interview with Dr. Ashwin Balagopal, assistant professor of medicine at the Johns Hopkins University School of Medicine about the impact that Dynavax Technologies Corporation (NASDAQ: DVAX)’s HBV-23 will have on the HBV vaccine market, particularly...